Drug discovery is becoming more expensive and producing less results than ever before (Eroom's Law) —why? One of the ballooning costs is clinical trials. Pharma/biotech often outsource their trials to CROs (Contract Research Organizations). But many CROs are incentivised to make trials as bloated and inefficient as possible. That means more money and less results. Our co-founder Meri Beckwith sits down with Dr. Mustafa Sultan, creator of The Big Picture Medicine Podcast, to talk through how we're building the anti-CRO (Lindus Health!) to solve this problem.
Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials
This collaboration is essential to eliminating traditional barriers in patient recruitment and reducing friction when transitioning between development stages and CRO partners, ultimately accelerating the delivery of breakthrough treatments to patients.
